Free Trial

Chromocell Therapeutics (CHRO) Stock Trends and Sentiment

$1.43
+0.01 (+1.00%)
(As of 05/24/2024 08:49 PM ET)

Media Mentions Over Time



View Trending Media Stocks
Recieve Chromocell Therapeutics News and Ratings via Email

Sign-up to receive the latest news and ratings for CHRO and its competitors with MarketBeat's FREE daily newsletter.

Related Companies and Tools

This page (NYSE:CHRO) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners